Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: J Nutr Biochem. 2021 Oct 25;100:108884. doi: 10.1016/j.jnutbio.2021.108884

Fig. 4.

Fig. 4.

Effects of 13’-COOHs and tocotrienols on human recombinant 5-LOX activity. The effect of tested compounds on human recombinant 5-LOX was examined using FOX assay as described in Materials and Methods. A – The effect of δT- and δTE-13’-COOH on 5-LOX activity. B - The effect of αTE, γTE and δTE on 5-LOX activity. The 5-LOX activity is normalized to solvent controls. Table – IC50s of tested compounds. *P<.05 and **P<.01 indicate significant differences between the treatment and solvent controls. Data are mean±SEM (n=3–5). Abbreviations are listed under Figure 2. #(7) in the table.

HHS Vulnerability Disclosure